상세 보기
Phase I/II open-label, umbrella platform designed study of investigational agents with or without pembrolizumab and/or chemotherapy in patients with advanced esophageal cancer previously treated with a PD-(L)1 inhibitor: KEYMAKER-U06 substudy 06B
- Sun, J-M.;
- Doi, T.;
- Enzinger, P. C.;
- Shah, M. A.;
- Adenis, A.;
- 외 5명
Citations
WEB OF SCIENCE
0Citations
SCOPUS
0- 제목
- Phase I/II open-label, umbrella platform designed study of investigational agents with or without pembrolizumab and/or chemotherapy in patients with advanced esophageal cancer previously treated with a PD-(L)1 inhibitor: KEYMAKER-U06 substudy 06B
- 저자
- Sun, J-M.; Doi, T.; Enzinger, P. C.; Shah, M. A.; Adenis, A.; Wu, J.; Sharan, K. P.; Bhagia, P.; Kato, K.; Shen, L.
- 발행일
- 2024-12
- 유형
- Meeting Abstract
- 권
- 35
- 페이지
- S1503 ~ S1503